Abstract
We report a draft genome sequence of Mycobacterium tuberculosis strain E186hv, belonging to the Beijing B0/W lineage and isolated from a patient from Kurgan, Russia. This clinical isolate showed a reduced virulence phenotype unusual for this lineage and resistance to isoniazid, rifampin, ethambutol, pyrazinamide, and ofloxacin. We analyzed single nucleotide polymorphisms (SNPs) associated with virulence.
GENOME ANNOUNCEMENT
The Beijing genotype is commonly present in the Russian population and in Eurasia as a whole. This lineage is characterized by high-level virulence (1–4).
For our analysis, we chose the Mycobacterium tuberculosis strain E186hv, isolated from a 53-year-old HIV-negative male patient from Kurgan, Russia, with secondary diagnosed fibrocavernous tuberculosis, provided by the Ural Research Institute for Phthisiopulmonology, Ekaterinburg, Russia. This strain was resistant to isoniazid (INH), rifampin (RIF), ethambutol (EMB), pyrazinamide (PZA), and ofloxacin (FLQ) and characterized as a strain with reduced virulence in the guinea pig model (5). The genomic DNA from Mycobacterium tuberculosis strain E186hv was purified by use of a PREP-NA kit (DNA-technology, Russia).
Genome sequencing was carried out on a Roche 454 GS Junior instrument (Roche, Switzerland) in the Laboratory of Bacterial Genetics, Vavilov Institute of General Genetics (Moscow, Russia). A total of 176,811 reads were generated. All reads were assembled to an initial draft genome of 4,334,870 nucleotides at 24-fold coverage using the GS De Novo Assembler (version 3.0; Roche). The resulting draft genome sequence consists of 137 contigs (overall G+C content, 65.5%). The automatic functional annotation results were obtained using the NCBI Prokaryotic Genome Annotation Pipeline (PGAAP) (http://www.ncbi.nlm.nih.gov/genome/annotation_prok/).
The E186hv genome contains 4,027 coding sequences (CDS), 3 rRNAs, and 45 tRNAs. A total of 83 pseudogenes, 5 noncoding RNAs (ncRNAs), 1 clustered regularly interspaced short palindromic repeat (CRISPR), and 55 frameshifted genes were predicted using the PGAAP.
According to housekeeping gene analysis (6), we classified this strain as belonging to the Beijing lineage. Analysis of the oxcA gene showed that this strain belongs to the B0/W subline. We compared our output sequence with the DNA sequence of the highly virulent M. tuberculosis W-148 strain, which belongs to the B0/W cluster of the Beijing group (7). In this announcement, we focused on genes which determine drug resistance and also virulence-associated loci, including the type II toxin-antitoxin (TA) systems (8, 9), type VII secretion genes (2), genes encoding WhiB-family proteins, including WhiB7 regulon (10, 11), and Ser/Thr protein kinases (STPKs) (12–14).
In the genes, we analyzed the single nucleotide polymorphisms (SNPs) associated with drug resistance to INH, RIF, PZA, EMB, and FLQ. We found SNPs in INH resistance genes (rv1592c, katG, fabD, and accD6), in the PZA resistance gene pncA, in RIF resistance genes (rpoB and embB), and in the FLQ resistance gene gyrA. We found synonymic changes in the EMB resistance genes embC and embA. The found amino acid substitution in KatG S315T does not affect the virulence level (15, 16), and thus the reduced virulence phenotype is determined by other factors.
The comparison of sequenced DNA with the W-148 sequence revealed the presence of 709 polymorphisms. We carried out a deeper analysis of genes involved in virulence. We did not identify genetic variants of VII-type secretion genes, STPKs genes, whiB1-7 genes, and the whiB7 regulon genes. We found only one SNP in the TA system—antitoxin gene vapB5 TC(167-168)CG. This mutation, as well as other SNPs associated with virulence (2, 4, 17), may impact the level of M. tuberculosis virulence and should be the subject for further functional analysis and validation in M. tuberculosis in future studies.
Nucleotide sequence accession numbers.
This whole-genome shotgun project has been deposited at GenBank under the accession number JXAW00000000 (Mycobacterium tuberculosis strain E186hv). The version described in this paper is version JXAW02000000.
ACKNOWLEDGMENTS
This research was supported by Russian Foundation for Basic Research (RFBR) (Russia) grant 13-04-91444 and National Institutes of Health (NIH) (USA) grants AI108535 and AI099512.
Footnotes
Citation Shur KV, Klimina KM, Zakharevich NV, Maslov DA, Bekker OB, Zaychikova MV, Kamaev EY, Kravchenko MA, Skornyakov SN, Zhang Y, Danilenko VN. 2015. Draft genome sequence of Mycobacterium tuberculosis strain E186hv of Beijing B0/W lineage with reduced virulence. Genome Announc 3(3):e00403-15. doi:10.1128/genomeA.00403-15.
REFERENCES
- 1.Reiling N, Homolka S, Walter K, Brandenburg J, Niwinski L, Ernst M, Herzmann C, Lange C, Diel R, Ehlers S, Niemann S. 2013. Clade-specific virulence patterns of Mycobacterium tuberculosis complex strains in human primary macrophages and aerogenically infected mice. mBio 4:e00250-13. doi: 10.1128/mBio.00250-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Prozorov AA, Fedorova IA, Bekker OB, Danilenko VN. 2014. The virulence factors of Mycobacterium tuberculosis: genetic control, new conceptions. Russ J Genet 50:775–797. doi: 10.1134/S1022795414080055. [DOI] [PubMed] [Google Scholar]
- 3.Mokrousov I, Narvskaya O, Vyazovaya A, Otten T, Jiao W-W, Gomes LL, Suffys PN, Shen A-D, Vishnevsky B. 2012. Russian “successful” clone B0/W148 of Mycobacterium tuberculosis Beijing genotype: a multiplex PCR assay for rapid detection and global screening. J Clin Microbiol 50:3757–3759. doi: 10.1128/JCM.02001-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Vishnevskiy BI, Manicheva OA, Yablonskiy PK. 2014. Mycobacterium tuberculosis virulence. Infektsiya i Immunitet 4:319–330. [Google Scholar]
- 5.Drabkina RO. 1963. Mikrobiologiya tuberkuleza. Medgiz, Moscow, USSR. [Google Scholar]
- 6.Homolka S, Projahn M, Feuerriegel S, Ubben T, Diel R, Nübel U, Niemann S. 2012. High resolution discrimination of clinical Mycobacterium tuberculosis complex strains based on single nucleotide polymorphisms. PLoS One 7:e39855. doi: 10.1371/journal.pone.0039855. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Lasunskaia E, Ribeiro SC, Manicheva O, Gomes LL, Suffys PN, Mokrousov I, Ferrazoli L, Andrade MR, Kritski A, Otten T, Kipnis TL, da Silva WD, Vishnevsky B, Oliveira MM, Gomes HM, Baptista IF, Narvskaya O. 2010. Emerging multidrug resistant Mycobacterium tuberculosis strains of the Beijing genotype circulating in Russia express a pattern of biological properties associated with enhanced virulence. Microbes Infect 12:467–475. doi: 10.1016/j.micinf.2010.02.008. [DOI] [PubMed] [Google Scholar]
- 8.Sala A, Bordes P, Genevaux P. 2014. Multiple toxin-antitoxin systems in Mycobacterium tuberculosis. Toxins (Basel) 6:1002–1020. doi: 10.3390/toxins6031002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Prozorov AA, Danilenko VN. 2010. Toxin-antitoxin systems in bacteria: apoptotic tools or metabolic regulators? Microbiology 79:129–140. doi: 10.1134/S0026261710020013.20411670 [DOI] [Google Scholar]
- 10.Larsson C, Luna B, Ammerman NC, Maiga M, Agarwal N, Bishai WR. 2012. Gene expression of Mycobacterium tuberculosis putative transcription factors whiB1-7 in redox environments. PLoS One 7:e37516. doi: 10.1371/journal.pone.0037516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Shur K, Maslov D, Bekker O, Alvarez-Figueroa M, Danilenko V. 2013. The WhiB7 gene polimorphism and its regulon genes in Mycobacterium tuberculosis, as a new mechanism of drug resistance. FEBS J 280(Suppl 1):366. doi: 10.1111/febs.12340. [DOI] [Google Scholar]
- 12.Canova MJ, Molle V. 2014. Bacterial serine/threonine protein kinases in host-pathogen interactions. J Biol Chem 289:9473–9479. doi: 10.1074/jbc.R113.529917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Cousin C, Derouiche A, Shi L, Pagot Y, Poncet S, Mijakovic I. 2013. Protein-serine/threonine/tyrosine kinases in bacterial signaling and regulation. FEMS Microbiol Lett 346:11–19. doi: 10.1111/1574-6968.12189. [DOI] [PubMed] [Google Scholar]
- 14.Maslov D, Zhukova Y, Bekker O, Alekseeva M, Danilenko V. 2013. Developing a Mycobacterium smegmatis based test-system for screening mycobacterial protein kinase PknB inhibitors—potential next generation anti-tuberculosis drugs. FEBS J 280(Suppl 1):280–281. doi: 10.1111/febs.12340. [DOI] [Google Scholar]
- 15.Pym AS, Saint-Joanis B, Cole ST. 2002. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect Immun 70:4955–4960. doi: 10.1128/IAI.70.9.4955-4960.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Zhang Y, Heym B, Allen B, Young D, Cole S. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591–593. doi: 10.1038/358591a0. [DOI] [PubMed] [Google Scholar]
- 17.Forrellad MA, Klepp LI, Gioffré A, Sabio y García J, Morbidoni HR, la Paz Santangelo M, Cataldi AA, Bigi F. 2013. Virulence factors of the Mycobacterium tuberculosis complex. Virulence 4:3–66. doi: 10.4161/viru.22329. [DOI] [PMC free article] [PubMed] [Google Scholar]